1. Home
  2. ORRF vs BCYC Comparison

ORRF vs BCYC Comparison

Compare ORRF & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORRF
  • BCYC
  • Stock Information
  • Founded
  • ORRF 1919
  • BCYC 2009
  • Country
  • ORRF United States
  • BCYC United Kingdom
  • Employees
  • ORRF N/A
  • BCYC N/A
  • Industry
  • ORRF Major Banks
  • BCYC Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORRF Finance
  • BCYC Health Care
  • Exchange
  • ORRF Nasdaq
  • BCYC Nasdaq
  • Market Cap
  • ORRF 608.7M
  • BCYC 566.5M
  • IPO Year
  • ORRF N/A
  • BCYC 2019
  • Fundamental
  • Price
  • ORRF $31.40
  • BCYC $7.14
  • Analyst Decision
  • ORRF Buy
  • BCYC Buy
  • Analyst Count
  • ORRF 3
  • BCYC 10
  • Target Price
  • ORRF $34.50
  • BCYC $25.00
  • AVG Volume (30 Days)
  • ORRF 147.8K
  • BCYC 238.3K
  • Earning Date
  • ORRF 07-22-2025
  • BCYC 08-05-2025
  • Dividend Yield
  • ORRF 3.29%
  • BCYC N/A
  • EPS Growth
  • ORRF N/A
  • BCYC N/A
  • EPS
  • ORRF 1.84
  • BCYC N/A
  • Revenue
  • ORRF $203,869,000.00
  • BCYC $25,722,000.00
  • Revenue This Year
  • ORRF $22.45
  • BCYC $7.35
  • Revenue Next Year
  • ORRF $3.45
  • BCYC N/A
  • P/E Ratio
  • ORRF $17.17
  • BCYC N/A
  • Revenue Growth
  • ORRF 56.29
  • BCYC N/A
  • 52 Week Low
  • ORRF $25.28
  • BCYC $6.10
  • 52 Week High
  • ORRF $41.99
  • BCYC $28.67
  • Technical
  • Relative Strength Index (RSI)
  • ORRF 60.34
  • BCYC 34.56
  • Support Level
  • ORRF $29.39
  • BCYC $7.11
  • Resistance Level
  • ORRF $31.94
  • BCYC $8.63
  • Average True Range (ATR)
  • ORRF 0.71
  • BCYC 0.48
  • MACD
  • ORRF 0.10
  • BCYC -0.14
  • Stochastic Oscillator
  • ORRF 78.82
  • BCYC 4.89

About ORRF Orrstown Financial Services Inc

Orrstown Financial Services Inc is a holding company engaged in commercial banking and trust business, this involves accepting demand, time, and savings deposits and granting loans. The company is also engaged in lending services for commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services that include checking, savings, time, and money market deposits. It also provides investment and brokerage services through its Financial Advisors division. The Company earns fees from its deposit clients for transaction-based account maintenance and overdraft services, It also earns wealth management and investment brokerage fees from its contracts with trusts. The company operates in a segment, namely Community Banking.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: